Market Closed -
Japan Exchange
11:30:00 02/05/2024 am IST
|
5-day change
|
1st Jan Change
|
2,344
JPY
|
-1.26%
|
|
-0.30%
|
-1.60%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
69,266
|
89,509
|
83,939
|
58,151
|
71,047
|
74,591
|
-
|
-
|
Enterprise Value (EV)
1 |
44,109
|
63,863
|
56,060
|
29,591
|
43,888
|
74,591
|
74,591
|
74,591
|
P/E ratio
|
20.1
x
|
25.8
x
|
23
x
|
16.9
x
|
22.1
x
|
24.1
x
|
23.3
x
|
22.6
x
|
Yield
|
2.88%
|
2.2%
|
2.35%
|
3.07%
|
2.72%
|
2.56%
|
2.56%
|
2.56%
|
Capitalization / Revenue
|
4.13
x
|
5.24
x
|
4.78
x
|
3.28
x
|
4.14
x
|
4.34
x
|
4.19
x
|
4.05
x
|
EV / Revenue
|
4.13
x
|
5.24
x
|
4.78
x
|
3.28
x
|
4.14
x
|
4.34
x
|
4.19
x
|
4.05
x
|
EV / EBITDA
|
13.2
x
|
17
x
|
15.2
x
|
10.9
x
|
-
|
16
x
|
15.3
x
|
14.7
x
|
EV / FCF
|
2,15,91,536
x
|
2,59,37,046
x
|
-
|
-
|
4,42,38,678
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
0%
|
-
|
-
|
-
|
Price to Book
|
1.74
x
|
2.23
x
|
2
x
|
1.49
x
|
1.64
x
|
1.7
x
|
1.65
x
|
1.6
x
|
Nbr of stocks (in thousands)
|
33,253
|
32,859
|
32,866
|
29,760
|
32,177
|
31,822
|
-
|
-
|
Reference price
2 |
2,083
|
2,724
|
2,554
|
1,954
|
2,208
|
2,344
|
2,344
|
2,344
|
Announcement Date
|
03/10/19
|
01/10/20
|
04/10/21
|
03/10/22
|
02/10/23
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
16,785
|
17,066
|
17,563
|
17,745
|
17,181
|
17,200
|
17,800
|
18,400
|
EBITDA
1 |
5,255
|
5,271
|
5,528
|
5,315
|
-
|
4,670
|
4,870
|
5,070
|
EBIT
1 |
4,918
|
4,937
|
5,212
|
5,031
|
4,604
|
4,400
|
4,600
|
4,800
|
Operating Margin
|
29.3%
|
28.93%
|
29.68%
|
28.35%
|
26.8%
|
25.58%
|
25.84%
|
26.09%
|
Earnings before Tax (EBT)
1 |
4,988
|
5,030
|
5,288
|
5,468
|
4,671
|
4,500
|
4,700
|
4,900
|
Net income
1 |
3,445
|
3,474
|
3,647
|
3,778
|
3,226
|
3,100
|
3,200
|
3,300
|
Net margin
|
20.52%
|
20.36%
|
20.77%
|
21.29%
|
18.78%
|
18.02%
|
17.98%
|
17.93%
|
EPS
2 |
103.6
|
105.5
|
111.0
|
115.8
|
100.0
|
97.40
|
100.6
|
103.7
|
Free Cash Flow
|
3,208
|
3,451
|
-
|
-
|
1,606
|
-
|
-
|
-
|
FCF margin
|
19.11%
|
20.22%
|
-
|
-
|
9.35%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
61.05%
|
65.47%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
93.12%
|
99.34%
|
-
|
-
|
49.78%
|
-
|
-
|
-
|
Dividend per Share
2 |
60.00
|
60.00
|
60.00
|
60.00
|
60.00
|
60.00
|
60.00
|
60.00
|
Announcement Date
|
03/10/19
|
01/10/20
|
04/10/21
|
03/10/22
|
02/10/23
|
-
|
-
|
-
|
Fiscal Period: August |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
---|
Net sales
1 |
7,051
|
10,015
|
8,069
|
9,494
|
3,378
|
4,439
|
7,817
|
5,800
|
4,128
|
9,928
|
2,954
|
4,977
|
7,931
|
5,256
|
3,048
|
7,392
|
5,591
|
4,220
|
9,811
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,739
|
3,198
|
2,275
|
2,937
|
915
|
1,120
|
2,035
|
1,905
|
1,091
|
2,996
|
631
|
1,228
|
1,859
|
1,681
|
657
|
1,608
|
1,733
|
1,060
|
2,793
|
Operating Margin
|
24.66%
|
31.93%
|
28.19%
|
30.94%
|
27.09%
|
25.23%
|
26.03%
|
32.84%
|
26.43%
|
30.18%
|
21.36%
|
24.67%
|
23.44%
|
31.98%
|
21.56%
|
21.75%
|
31%
|
25.12%
|
28.47%
|
Earnings before Tax (EBT)
1 |
1,793
|
3,237
|
2,313
|
2,975
|
940
|
1,137
|
2,077
|
2,268
|
-
|
-
|
648
|
-
|
1,889
|
1,708
|
676
|
1,639
|
1,753
|
1,108
|
2,861
|
Net income
1 |
1,236
|
2,238
|
1,595
|
2,052
|
648
|
785
|
1,433
|
1,569
|
776
|
2,345
|
445
|
850
|
1,295
|
1,185
|
464
|
1,129
|
1,160
|
811
|
1,971
|
Net margin
|
17.53%
|
22.35%
|
19.77%
|
21.61%
|
19.18%
|
17.68%
|
18.33%
|
27.05%
|
18.8%
|
23.62%
|
15.06%
|
17.08%
|
16.33%
|
22.55%
|
15.22%
|
15.27%
|
20.75%
|
19.22%
|
20.09%
|
EPS
|
37.45
|
-
|
48.57
|
-
|
19.74
|
-
|
43.63
|
48.02
|
-
|
-
|
13.82
|
-
|
40.16
|
36.73
|
14.53
|
35.39
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
02/04/20
|
01/10/20
|
05/04/21
|
04/10/21
|
27/12/21
|
04/04/22
|
04/04/22
|
29/06/22
|
03/10/22
|
03/10/22
|
27/12/22
|
04/04/23
|
04/04/23
|
29/06/23
|
27/12/23
|
02/04/24
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
25,157
|
25,646
|
27,879
|
28,560
|
27,159
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
3,208
|
3,451
|
-
|
-
|
1,606
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
8.8%
|
8.7%
|
8.9%
|
9%
|
7.5%
|
7.1%
|
7.2%
|
7.2%
|
ROA (Net income/ Total Assets)
|
11.5%
|
11.3%
|
11.6%
|
11%
|
9.87%
|
9.2%
|
9.3%
|
9.5%
|
Assets
1 |
30,005
|
30,801
|
31,397
|
34,470
|
32,696
|
33,696
|
34,409
|
34,737
|
Book Value Per Share
2 |
1,195
|
1,221
|
1,279
|
1,310
|
1,346
|
1,377
|
1,418
|
1,461
|
Cash Flow per Share
|
114.0
|
116.0
|
121.0
|
124.0
|
108.0
|
-
|
-
|
-
|
Capex
1 |
225
|
146
|
239
|
94.2
|
206
|
200
|
250
|
250
|
Capex / Sales
|
1.34%
|
0.85%
|
1.36%
|
0.53%
|
1.2%
|
1.16%
|
1.4%
|
1.36%
|
Announcement Date
|
03/10/19
|
01/10/20
|
04/10/21
|
03/10/22
|
02/10/23
|
-
|
-
|
-
|
Last Close Price
2,344
JPY Average target price
2,000
JPY Spread / Average Target -14.68% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.60% | 488M | | +11.40% | 27.92B | | -30.75% | 3.08B | | -15.97% | 2.53B | | +18.11% | 2.47B | | +7.78% | 2.1B | | -9.47% | 1.91B | | -0.56% | 1.51B | | +2.24% | 1.34B | | +24.32% | 1.24B |
Medical Supplies
|